---
figid: PMC5337359__PPAR2017-5879090.001
figtitle: Interactions between the canonical Wnt/beta-catenin pathway and PPAR gamma
  under aerobic glycolysis conditions in colon cancer
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC5337359
filename: PPAR2017-5879090.001.jpg
figlink: /pmc/articles/PMC5337359/figure/fig1/
number: F1
caption: 'A model of interactions between the canonical Wnt/beta-catenin pathway and
  PPAR gamma under aerobic glycolysis conditions in colon cancer. In the absence of
  the Wnt ligand (“off state”), cytosolic beta-catenin is phosphorylated by GSK-3
  beta. APS and AXIN combine with GSK-3 beta and beta-catenin to enhance the destruction
  process in the proteasome (beta-catenin proteasomal degradation: CPD). In the presence
  of the Wnt ligand (“on state”), Wnt binds both Frizzled and LRP5/6 receptors to
  initiate LRP phosphorylation and dishevelled-mediated Frizzled internalization.
  This leads to dissociation of the AXIN/APC/GSK-3 beta complex. Beta-catenin phosphorylation
  is inhibited. Thus, beta-catenin accumulates in the cytosol and then translocates
  to the nucleus to bind TCF-LEF cotranscription factors, which induce the Wnt-response
  gene transcription (PDK, MCT-1, cMyc, and cyclin D1). Glucose itself activates the
  Wnt pathway. PPAR gamma via APC activates CPD. PPAR gamma inhibits the beta-catenin-TCF/LEF
  complex. Beta-catenin binds PPAR gamma CBD. PDK inhibits the PDH complex in mitochondria.
  Thus pyruvate cannot be converted into acetyl-CoA and enters the TCA cycle. Myc
  activates LDH-A which converts cytosolic pyruvate into lactate. MCT-1 favors lactate
  secretion from the cytosol which favors angiogenesis. cMyc increases glutamine entry
  in the cytosol and mitochondria. Myc-induced glutamine enhances nucleotide synthesis.
  Abbreviations are as follows: adenomatous polyposis coli (APC); alpha ceto-glutarate
  (a-KG); beta-catenin proteasomal degradation: CPD; catenin binding domain (CBD);
  Dishevelled (Dsh); Frizzled (Fzd); glycogen synthase kinase-3beta (GSK-3beta); lactate
  dehydrogenase (LDH); low-density lipoprotein receptor-related protein 5/6 (LRP5/6);
  monocarboxylate lactate transporter-1 (MCT-1); peroxisome proliferator-activated
  receptor gamma (PPAR gamma); pyruvate dehydrogenase complex (PDH); pyruvate dehydrogenase
  kinase (PDK); T-cell factor/lymphoid enhancer factor (TCF/LEF); tricarboxylic acid
  (TCA); ∗: Wnt targets: PDK, cMyc, MCT-1, and cyclin D1.'
papertitle: Interactions between PPAR Gamma and the Canonical Wnt/Beta-Catenin Pathway
  in Type 2 Diabetes and Colon Cancer.
reftext: Yves Lecarpentier, et al. PPAR Res. 2017;2017:5879090.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9657499
figid_alias: PMC5337359__F1
figtype: Figure
redirect_from: /figures/PMC5337359__F1
ndex: 5e5dbad4-deb1-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5337359__PPAR2017-5879090.001.html
  '@type': Dataset
  description: 'A model of interactions between the canonical Wnt/beta-catenin pathway
    and PPAR gamma under aerobic glycolysis conditions in colon cancer. In the absence
    of the Wnt ligand (“off state”), cytosolic beta-catenin is phosphorylated by GSK-3
    beta. APS and AXIN combine with GSK-3 beta and beta-catenin to enhance the destruction
    process in the proteasome (beta-catenin proteasomal degradation: CPD). In the
    presence of the Wnt ligand (“on state”), Wnt binds both Frizzled and LRP5/6 receptors
    to initiate LRP phosphorylation and dishevelled-mediated Frizzled internalization.
    This leads to dissociation of the AXIN/APC/GSK-3 beta complex. Beta-catenin phosphorylation
    is inhibited. Thus, beta-catenin accumulates in the cytosol and then translocates
    to the nucleus to bind TCF-LEF cotranscription factors, which induce the Wnt-response
    gene transcription (PDK, MCT-1, cMyc, and cyclin D1). Glucose itself activates
    the Wnt pathway. PPAR gamma via APC activates CPD. PPAR gamma inhibits the beta-catenin-TCF/LEF
    complex. Beta-catenin binds PPAR gamma CBD. PDK inhibits the PDH complex in mitochondria.
    Thus pyruvate cannot be converted into acetyl-CoA and enters the TCA cycle. Myc
    activates LDH-A which converts cytosolic pyruvate into lactate. MCT-1 favors lactate
    secretion from the cytosol which favors angiogenesis. cMyc increases glutamine
    entry in the cytosol and mitochondria. Myc-induced glutamine enhances nucleotide
    synthesis. Abbreviations are as follows: adenomatous polyposis coli (APC); alpha
    ceto-glutarate (a-KG); beta-catenin proteasomal degradation: CPD; catenin binding
    domain (CBD); Dishevelled (Dsh); Frizzled (Fzd); glycogen synthase kinase-3beta
    (GSK-3beta); lactate dehydrogenase (LDH); low-density lipoprotein receptor-related
    protein 5/6 (LRP5/6); monocarboxylate lactate transporter-1 (MCT-1); peroxisome
    proliferator-activated receptor gamma (PPAR gamma); pyruvate dehydrogenase complex
    (PDH); pyruvate dehydrogenase kinase (PDK); T-cell factor/lymphoid enhancer factor
    (TCF/LEF); tricarboxylic acid (TCA); ∗: Wnt targets: PDK, cMyc, MCT-1, and cyclin
    D1.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - RPSA
  - LRP1
  - PTPRA
  - MVP
  - LRP6
  - LRP5
  - SERPINA3
  - ACTG1
  - ACTG2
  - FHL5
  - ACOT7
  - ACTBL2
  - POTEKP
  - POTEM
  - ADAR
  - DVL1P1
  - MCTS1
  - LDHA
  - AXIN1
  - AXIN2
  - MYC
  - OPN1MW
  - PDK1
  - PDK2
  - PDK3
  - PDK4
  - PDP1
  - DLAT
  - DLD
  - PDHA1
  - PDHA2
  - PDHB
  - PDHX
  - CTNNB1
  - CCND1
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - HNF4A
  - CPD
  - HOMER2
  - APC
  - PROC
  - Aspartate
  - Glucose
  - Glutamine
  - Pyruvate
  - Lactate
  - Cancer
---
